Laurion Capital Management LP purchased a new position in Calyxt Inc (NASDAQ:CLXT) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 61,611 shares of the company’s stock, valued at approximately $1,150,000. Laurion Capital Management LP owned approximately 0.19% of Calyxt as of its most recent SEC filing.

Several other large investors have also bought and sold shares of CLXT. PNC Financial Services Group Inc. acquired a new position in shares of Calyxt in the second quarter worth $186,000. Granite Investment Partners LLC purchased a new stake in shares of Calyxt during the 2nd quarter worth $216,000. Citadel Advisors LLC purchased a new stake in shares of Calyxt during the 2nd quarter worth $342,000. Deutsche Bank AG lifted its position in shares of Calyxt by 151.3% during the 4th quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock worth $404,000 after purchasing an additional 11,064 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its position in shares of Calyxt by 23.6% during the 1st quarter. Wells Fargo & Company MN now owns 38,048 shares of the company’s stock worth $500,000 after purchasing an additional 7,260 shares during the last quarter. Institutional investors and hedge funds own 28.07% of the company’s stock.

In related news, Director Michel Arbadji sold 6,500 shares of the business’s stock in a transaction on Wednesday, June 20th. The shares were sold at an average price of $22.00, for a total value of $143,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Daniel F. Voytas sold 4,666 shares of the business’s stock in a transaction on Friday, July 20th. The shares were sold at an average price of $17.94, for a total transaction of $83,708.04. Following the completion of the sale, the insider now directly owns 97,648 shares of the company’s stock, valued at $1,751,805.12. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,237 shares of company stock valued at $623,530. 2.80% of the stock is owned by corporate insiders.

Several research firms have recently issued reports on CLXT. Zacks Investment Research raised shares of Calyxt from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a research report on Monday, May 28th. Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 price objective on shares of Calyxt in a research report on Friday, June 22nd. ValuEngine raised shares of Calyxt from a “hold” rating to a “buy” rating in a research report on Friday, July 20th. Finally, Goldman Sachs Group began coverage on shares of Calyxt in a research report on Friday, September 7th. They set a “neutral” rating and a $18.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Calyxt currently has a consensus rating of “Buy” and a consensus target price of $26.04.

Calyxt stock opened at $16.05 on Friday. The firm has a market cap of $516.57 million, a PE ratio of -14.33 and a beta of 3.47. Calyxt Inc has a 12-month low of $13.09 and a 12-month high of $31.89. The company has a debt-to-equity ratio of 0.16, a current ratio of 21.27 and a quick ratio of 21.27.

Calyxt (NASDAQ:CLXT) last released its quarterly earnings data on Wednesday, August 1st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.03). The firm had revenue of $0.20 million for the quarter, compared to analysts’ expectations of $0.10 million. Calyxt had a negative return on equity of 45.34% and a negative net margin of 7,253.78%. sell-side analysts forecast that Calyxt Inc will post -1.02 earnings per share for the current year.

Calyxt Profile

Calyxt, Inc is a consumer-centric, food and agriculture focused company. It engages in the development of specialty food ingredients, such as healthier oils, high fiber wheat, and food crops with desirable traits, such as herbicide tolerance. The company provides healthier food ingredients for consumers and agriculturally advantageous traits for farmers.

Recommended Story: Fundamental Analysis and Choosing Stocks

Institutional Ownership by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.